Month: April 2022

HUNTINGTON BEACH, CA, April 08, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — One World Universe Inc. (OTC: OWUV), a publicly traded company that invests in sports related businesses, distressed assets, business opportunities within emerging industries such as the Metaverse, and providing humanitarian efforts in over 185 countries, was engaged by six defunct expert market companies requesting the services of Dysfunctional Rehabilitation Inc. to regain compliance with the SEC and become a tradable Pink Current Stock.  One World Universe Inc. is gaining traction with its subsidiary company, Dysfunctional Rehabilitation Inc. This week, six expert market companies reached out to One World Universe Inc. requesting services from Dysfunctional Rehabilitation Inc. and the expertise of Chief Financial Officer, Caren Currier, to regain...

Totalbanken har som del af den løbende proces med at optimere bankens sammensætning af nedskrivningsegnede passiver (NEP) indgået aftale om at udstede 50 mio. kr. ikke-foranstillet seniorgæld (Senior Non-Preferred). Obligationerne har en løbetid på 5 år med mulighed for førtidig indfrielse efter 4 år, forudsat Finanstilsynets forudgående tilladelse. Obligationerne forrentes med en variabel halvårlig kuponrente på CIBOR6 plus et kreditspænd på 240 bps.Attachment2022-06 Totalbanken udsteder 50 mio.kr. Senior Non-Preferred

The Annual General Meeting of Hofseth BioCare ASA will be held at the company’s premises at Kipervikgata 13, 6003 Ålesund, on 29 April 2022 at 13:00 CET. Please find the notice to the Annual General Meeting attached and relevant documents referred to in the notice are made available on www.hofsethbiocare.com. For further information, please contact: Jon Olav Ødegård, CFO of Hofseth BioCare ASA Phone: +47 93632966 E-mail: joo@hofsethbiocare.no About Hofseth BioCare ASA HBC is a Norwegian consumer and pet health ingredient supplier and an incubator for new drug leads. Research is ongoing to identify the individual elements within its ingredients that modulate inflammation and the immune response with pre-clinical studies in multiple clinics and university research labs in several countries. Lead clinical and pre-clinical candidates...

Stockholm, 8 April 2022 – Anoto Group AB (publ) (“Anoto”) announced in a press release on 6 April 2022 that the loan Anoto received from Swedish investors that was announced in a press release on 10 August 2021 now partially is converted into shares. The conversion referred to is carried out through an offset issue. The Board of Directors of Anoto has, on the basis of an authorization from the Annual General Meeting held on 30 June 2021, resolved on an offset issue of 6,666,666 shares (the “Offset issue”). Through the Offset issue, Anoto receives MSEK 5 through set-off before issue costs. The disapplication of the shareholders´ preferential rights are for Anoto to be able fulfill its obligations according to the loan agreement entered into. The subscription price for the Offset issue is 0.75 SEK per share, which corresponds to the volume-weighted...

MAINZ, Germany, April 8, 2022 — BioNTech SE (Nasdaq: BNTX) today announced that it is one of the companies in Germany to be granted a pandemic preparedness contract by the Federal Republic of Germany. The framework agreement is aimed at pandemic preparedness including manufacturing and supply of mRNA vaccines in emergency situations in Germany. “There is growing evidence that viral pandemics will continue to pose a public health challenge for years. This contract with the German government will ensure significant supply of vaccine doses to address potential public health threats by 2027,” said Sean Marett, Chief Business and Chief Commercial Officer at BioNTech. “We are proud to be in a position to be a long-term partner for Germany and remain steadfast in our commitment to continued investments in research and development aimed at bringing...

PEMBROKE, Bermuda, April 08, 2022 (GLOBE NEWSWIRE) — Sompo International, a leading global provider of commercial and consumer property and casualty (re)insurance, announced today the appointment of Kenneth Reilly as Executive Vice President, General Manager, Global Business Department, Sompo Holdings and Executive Vice President, Head of the new Sompo International Tokyo office, effective July 1, 2022. Ken will report to both Mikio Okumura, Chief Operating Officer, Sompo Holdings and James Shea, Chairman and CEO, Sompo International. James Shea shared, “Establishing our new Sompo International office in Tokyo is a big step forward towards increasing collaboration and education amongst the employees of Sompo International and the Sompo Insurance companies in Japan. I’m very excited to have Ken join to lead these efforts. Ken...

RESEARCH TRIANGLE PARK, N.C., April 08, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company has paused enrollment in clinical trials with BCX9930 while the company investigates elevated serum creatinine levels seen in some patients. During the investigation, the company will not enroll new patients in the REDEEM-1, REDEEM-2 or RENEW clinical trials. Patients currently enrolled in the trials are continuing on study drug at this time. About BioCryst Pharmaceuticals BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease. Oral, once-daily ORLADEYO® (berotralstat) is approved in the United States, the European Union, Japan,...